首页|小青龙汤治疗慢性阻塞性肺疾病急性加重期临床效果

小青龙汤治疗慢性阻塞性肺疾病急性加重期临床效果

Clinical Efficacy of Xiaoqinglong Decoction in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

扫码查看
目的:分析小青龙汤加减治疗慢性阻塞性肺疾病急性加重期(AECOPD)外寒内饮证患者的有效性和安全性.方法:选取佛山市禅城区人民医院2020 年 5 月至2022 年 6 月期间收治的AECOPD患者92 例为研究对象,根据随机数字表法分为对照组和观察组,各46 例.对照组患者给予常规西医基础治疗,观察组患者在对照组基础上给予小青龙汤加减治疗,比较两组患者治疗前后中医证候评分(咳嗽、咯痰、喘息、胸闷、气短及喉中痰鸣)、外周血分化抗原(CD)4+、CD8+、CD4+/CD8+、肿瘤坏死因子-α(TNF-α)、降钙素原(PCT)及一氧化氮(NO)水平,血、尿、粪便及肝肾功能检查指标,治疗过程中不良反应事件.结果:治疗后两组患者各项中医证候评分均较治疗前降低,且治疗后观察组患者各项中医证候评分均低于对照组,差异具有统计学意义(P<0.05).治疗后两组患者血清PCT、TNF-α、NO水平均较治疗前降低,且治疗后观察组患者血清PCT、TNF-α、NO水平均低于对照组,差异具有统计学意义(P<0.05).治疗后两组患者外周血CD4+水平、CD4+/CD8+比值均较治疗前升高,CD8+较治疗前降低,治疗后观察组患者外周血CD4+水平、CD4+/CD8+比值高于对照组,CD8+低于对照组,差异具有统计学意义(P<0.05).治疗后两组患者肝肾功能指标、血、尿、便常规未见明显异常,治疗过程中两组患者均未发生任何不良事件.结论:常规西医基础治疗联合小青龙汤加减治疗可以更好地缓解AECOPD外寒内饮证患者中医证候,改善免疫功能、炎症和氧化应激指标,安全性高.
Objective To analyze the efficacy and safety of Xiaoqinglong decoction in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD)with exterior cold and interior fluid retention syndrome.Methods Ninety-two AECOPD patients admitted to Chancheng District People's Hospital of Foshan City from May 2020 to June 2022 were selected as the research subjects.According to the random number table method,they were divided into a control group and an observation group,with 46 cases in each group.The control group received conventional Western medicine treatment,while the observation group received Xiaoqinglong decoction treatment on the basis of the control group.The Traditional Chinese Medicine(TCM)syndrome scores(cough,expectoration,wheezing,chest tightness,shortness of breath,and phlegm noise in the throat),the peripheral blood levels of cluster of differentiation(CD)4+,CD8+,CD4+/CD8+,tumor necrosis factor-α(TNF-α),procalcitonin(PCT),and nitric oxide(NO),as well as blood,urine,stool,and liver and kidney function test indicators,and adverse events during treatment were compared between the two groups before and after treatment.Results After treatment,the TCM syndrome scores of both groups were lower than those before treatment,and the TCM syndrome scores of the observation group were lower than those of the control group,with statistically significant differences(P<0.05).After treatment,the serum levels of PCT,TNF-α,and NO of both groups were lower than those before treatment,and the serum levels of PCT,TNF-α,and NO of the observation group were lower than those of the control group,with statistically significant differences(P<0.05).After treatment,the CD4+ and the ratio of CD4+/CD8+ of both groups were higher than those before treatment,and CD8+ was lower than that before treatment.The peripheral blood levels of CD4+ and the ratio of CD4+/CD8+ of the observation group were higher than those of the control group,and CD8+ was lower than that of the control group,with statistically significant differences(P<0.05).After treatment,there were no significant abnormalities in liver and kidney function indicators,blood,urine,and stool routine in both groups,and no adverse events occurred in either group during the treatment.Conclusion Conventional Western medicine treatment combined with Xiaoqinglong decoction can better relieve the TCM syndromes of AECOPD patients with exterior cold and interior fluid retention syndrome,improve immune function,inflammation,and oxidative stress indicators,with high safety.

Acute exacerbation of chronic obstructive pulmonary diseaseExterior cold and interior fluid retention syndromeXiaoqinglong decoction

成军家、陈嘉怡、蔡琳冰、邵宝琪

展开 >

佛山市禅城区人民医院,广东 佛山 528000

慢性阻塞性肺疾病急性加重期 外寒内饮证 小青龙汤

2024

深圳中西医结合杂志
深圳市中西医结合临床研究所

深圳中西医结合杂志

影响因子:0.692
ISSN:1007-0893
年,卷(期):2024.34(3)
  • 15